1-Owen RJ. Bacteriology of Helicobacter pylori.Bailliere's clinical gastroenterology. 1995 Sep;9(3):415-46. 2-Frydman GH, Davis N, Beck PL, Fox JG. Helicobacter pylori Eradication in Patients with Immune Thrombocytopenic Purpura: A Review and the Role of Biogeography. Helicobacter. 2015 Aug;20(4):239-51. 3-Yong X, Tang B, Li BS, Xie R, Hu CJ, Luo G, et al. Helicobacter pylori virulence factor CagA promotes tumorigenesis of gastric cancer via multiple signaling pathways. Cell communication and signaling : CCS. 2015 Jul 11;13:30. 4-Taylor JM, Ziman ME, Canfield DR, Vajdy M, Solnick JV. Effects of a Th1- versus a Th2-biased immune response in protection against Helicobacter pylori challenge in mice. Microbial pathogenesis. 2008 Jan;44(1):20-7. 5-Marotti B, Rocco A, De Colibus P, Compare D, de Nucci G, Staibano S, et al. Interleukin-13 mucosal production in Helicobacter pylori-related gastric diseases. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2008 Apr;40(4):240-7. 6-Martinez-Becerra F, Castillo-Rojas G, Ponce de Leon S, Lopez-Vidal Y. IgG subclasses against Helicobacter pylori isolates: an important tool for disease characterization. Scandinavian journal of immunology. 2012 Jul;76(1):26-32. 7-Watanabe M, Kato J, Inoue I, Yoshimura N, Yoshida T, Mukoubayashi C, et al. Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis. International journal of cancer. 2012 Dec 01;131(11):2632-42. 8-Ling V, Wu PW, Finnerty HF, Agostino MJ, Graham JR, Chen S, et al. Assembly and annotation of human chromosome 2q33 sequence containing the CD28, CTLA4, and ICOS gene cluster: analysis by computational, comparative, and microarray approaches. Genomics. 2001 Dec;78(3):155-68. 9-Suzuki T, Kato K, Ohara S, Noguchi K, Sekine H, Nagura H, et al. Localization of antigen-presenting cells in Helicobacter pylori-infected gastric mucosa. Pathology international. 2002 Apr;52(4):265-71. 10-Zhuang Y, Shi Y, Liu XF, Zhang JY, Liu T, Fan X, et al. Helicobacter pylori-infected macrophages induce Th17 cell differentiation. Immunobiology. 2011 Jan-Feb;216(1-2):200-7. 11-Khamri W, Walker MM, Clark P, Atherton JC, Thursz MR, Bamford KB, et al. Helicobacter pylori stimulates dendritic cells to induce interleukin-17 expression from CD4+ T lymphocytes. Infection and immunity. 2010 Feb;78(2):845-53. 12- Shimada M, Ando T, Peek RM, Watanabe O, Ishiguro K, Maeda O, et al. Helicobacter pylori infection upregulates interleukin-18 production from gastric epithelial cells. European journal of gastroenterology & hepatology. 2008 Dec;20(12):1144-50. 13-Sakitani K, Hirata Y, Hayakawa Y, Serizawa T, Nakata W, Takahashi R, et al. Role of interleukin-32 in Helicobacter pylori-induced gastric inflammation. Infection and immunity. 2012 Nov;80(11):3795-803. PubMed PMID: 22890997. 14-Chang LL, Wang Sw Fau - Wu IC, Wu Ic Fau - Yu F-J, Yu Fj Fau - Su Y-C, Su Yc Fau - Chen Y-P, Chen Yp Fau - Wu D-C, et al. Impaired dendritic cell maturation and IL-10 production following H. pylori stimulation in gastric cancer patients. 15-Okayama N, Hamanaka Y, Suehiro Y, Hasui Y, Nakamura J, Hinoda Y. Association of interleukin-10 promoter single nucleotide polymorphisms -819 T/C and -592 A/C with aging. The journals of gerontology Series A, Biological sciences and medical sciences. 2005 Dec;60(12):1525-9. 16-Fickenscher H, Hor S, Kupers H, Knappe A, Wittmann S, Sticht H. The interleukin-10 family of cytokines. Trends in immunology. 2002 Feb;23(2):89-96. 17-Azuma YT1, Nakajima H, Takeuchi T. IL-19 as a potential therapeutic in autoimmune and inflammatory diseases. Curr Pharm Des. 2011 Nov;17(34):3776-80. 18-Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. The Journal of experimental medicine. 2001 Jun 04;193(11):1285-94. 19-Bimczok D, Clements RH, Waites KB, Novak L, Eckhoff DE, Mannon PJ, et al. Human primary gastric dendritic cells induce a Th1 response to H. pylori. Mucosal immunology. 2010 May;3(3):260-9. PubMed PMID: 20237463. 20-Dumoutier L, Leemans C, Lejeune D, Kotenko SV, Renauld JC. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. Journal of immunology. 2001 Oct 01;167(7):3545-9. 21-Commins S, Steinke JW, Borish L. The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. The Journal of allergy and clinical immunology. 2008 May;121(5):1108-11. 22-Liao YC, Liang WG, Chen FW, Hsu JH, Yang JJ, Chang MS. IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha. Journal of immunology. 2002 Oct 15;169(8):4288-97. 23-Sakurai N, Kuroiwa T, Ikeuchi H, Hiramatsu N, Maeshima A, Kaneko Y, et al. Expression of IL-19 and its receptors in RA: potential role for synovial hyperplasia formation. Rheumatology. 2008 Jun;47(6):815-20. 24-Okayama N, Suehiro Y, Hamanaka Y, Nakamura J, Hinoda Y. Association of interleukin-19 gene polymorphisms with age. The journals of gerontology Series A, Biological sciences and medical sciences. 2007 May;62(5):507-11 . 25-Munnangi S, Sonnenberg A. Time trends of physician visits and treatment patterns of peptic ulcer disease in the United States. Archives of internal medicine. 1997 Jul 14;157(13):1489-94. 26-Lamb A, Chen LF. Role of the Helicobacter pylori-induced inflammatory response in the development of gastric cancer. Journal of cellular biochemistry. 2013 Mar;114(3):491-7. 27-Watanabe T, Asano N, Fichtner-Feigl S, Gorelick PL, Tsuji Y, Matsumoto Y, et al. NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway. The Journal of clinical investigation. 2010 May;120(5):1645-62. 28-Boniface K, Guignouard E, Pedretti N, Garcia M, Delwail A, Bernard FX, et al. A role for T cell-derived interleukin 22 in psoriatic skin inflammation. Clinical and experimental immunology. 2007 Dec;150(3):407-15. 29-Fuse S, Molloy MJ, Usherwood EJ. Immune responses against persistent viral infections: possible avenues for immunotherapeutic interventions. Critical reviews in immunology. 2008;28(2):159-83. 30-Velin D, Favre L, Bernasconi E, Bachmann D, Pythoud C, Saiji E, et al. Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model. Gastroenterology. 2009 Jun;136(7):2237-46 e1. 31-Cooley ID, Chauhan VS, Donneyz MA, Marriott I. Astrocytes produce IL-19 in response to bacterial challenge and are sensitive to the immunosuppressive effects of this IL-10 family member.Glia.2014 May;62(5):818-28. 32-Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA, Easton DF. A systematic review of genetic polymorphisms and breast cancer risk. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 1999 Oct;8(10):843-54. 33-Roberts-Thomson IC, Butler WJ. Polymorphism and gastric cancer. Journal of gastroenterology and hepatology. 2005 May;20(5):793-4. 34-Freire de Melo F, Rocha AM, Rocha GA, Pedroso SH, de Assis Batista S, Fonseca de Castro LP, et al. A regulatory instead of an IL-17 T response predominates in Helicobacter pylori-associated gastritis in children. Microbes and infection. 2012 Apr;14(4):341-7. 35-ogawa S, Joh T, Itoh M, Katsuda N, Ito H, Matsuo K, et al. Interleukin-2 gene polymorphisms associated with increased risk of gastric atrophy from Helicobacter pylori infection. Helicobacter. 2005 Jun;10(3):172-8.